GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | January 22, 2025 |
PDB ID ▲ | UniProt ID | Title | Descriptor |
---|---|---|---|
7K80 | P43629 | KIR3DL1*001 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide | |
7K81 | A0A411J078 | KIR3DL1*005 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide | |
7K81 | P61769 | KIR3DL1*005 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide | |
7K81 | 7K81 | KIR3DL1*005 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide | |
7K81 | I6LEL9 | KIR3DL1*005 in complex with HLA-A*24:02 presenting the RYPLTFGW peptide | |
7K8M | 7K8M | Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C102 | |
7K8M | P0DTC2 | Structure of the SARS-CoV-2 receptor binding domain in complex with the human neutralizing antibody Fab fragment, C102 | |
7K8S | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1) | |
7K8S | 7K8S | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C002 (state 1) | |
7K8T | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2) | |
7K8T | 7K8T | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C002 (State 2) | |
7K8U | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104 | |
7K8U | 7K8U | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C104 | |
7K8V | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110 | |
7K8V | 7K8V | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C110 | |
7K8W | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119 | |
7K8W | 7K8W | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C119 | |
7K8X | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1) | |
7K8X | 7K8X | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 1) | |
7K8Y | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2) | |
7K8Y | 7K8Y | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C121 (State 2) | |
7K8Z | P0DTC2 | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135 | |
7K8Z | 7K8Z | Structure of the SARS-CoV-2 S 2P trimer in complex with the human neutralizing antibody Fab fragment, C135 | |
7K90 | P0DTC2 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144 | |
7K90 | 7K90 | Structure of the SARS-CoV-2 S 6P trimer in complex with the human neutralizing antibody Fab fragment, C144 | |
7K93 | D0EPS0 | DENV2 NS1 in complex with neutralizing 2B7 single chain Fab variable region (scFv) | |
7K93 | 7K93 | DENV2 NS1 in complex with neutralizing 2B7 single chain Fab variable region (scFv) | |
7K9H | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation) | |
7K9H | 7K9H | SARS-CoV-2 Spike in complex with neutralizing Fab 2B04 (one up, two down conformation) | |
7K9I | P0DTC2 | SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2B04 (local refinement) | |
7K9I | 7K9I | SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2B04 (local refinement) | |
7K9J | P0DTC2 | SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation) | |
7K9J | 7K9J | SARS-CoV-2 Spike in complex with neutralizing Fab 2H04 (three down conformation) | |
7K9K | P0DTC2 | SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2H04 (local refinement) | |
7K9K | 7K9K | SARS-CoV-2 Spike RBD in complex with neutralizing Fab 2H04 (local refinement) | |
7K9Z | 7K9Z | Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutralizing antibodies 298 and 52 | |
7K9Z | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with the Fab fragments of neutralizing antibodies 298 and 52 | |
7KBI | P02879 | Ricin bound to VHH antibody V5E1 | |
7KBI | 7KBI | Ricin bound to VHH antibody V5E1 | |
7KBK | P02879 | Ricin bound to VHH antibody V6E11 | |
7KBK | 7KBK | Ricin bound to VHH antibody V6E11 | |
7KBT | P00451 | Factor VIII in complex with the anti-C2 domain antibody, G99 | |
7KBT | P12263 | Factor VIII in complex with the anti-C2 domain antibody, G99 | |
7KBT | 7KBT | Factor VIII in complex with the anti-C2 domain antibody, G99 | |
7KBU | Q8N4S1 | Structure of Hevin FS-EC | |
7KC1 | L0HR89 | Cryo-EM structure of SRR2899884.46167H+MEDI8852L fab in complex with Victoria HA | |
7KC1 | M1E1E4 | Cryo-EM structure of SRR2899884.46167H+MEDI8852L fab in complex with Victoria HA | |
7KC1 | A0A2P1E3C0 | Cryo-EM structure of SRR2899884.46167H+MEDI8852L fab in complex with Victoria HA | |
7KC1 | 7KC1 | Cryo-EM structure of SRR2899884.46167H+MEDI8852L fab in complex with Victoria HA | |
7KC4 | Q5T9L3 | Human WLS in complex with WNT8A |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024